NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1658.550.9 (+0.05 %)
PREV CLOSE ( ) 1657.65
OPEN PRICE ( ) 1659.65
BID PRICE (QTY) 1657.55 (9)
OFFER PRICE (QTY) 1660.30 (1)
VOLUME 1789
TODAY'S LOW / HIGH ( )1651.65 1673.20
52 WK LOW / HIGH ( )900 1711.95
NSE1659.80-7.3 (-0.44 %)
PREV CLOSE( ) 1667.10
OPEN PRICE ( ) 1661.35
BID PRICE (QTY) 1657.20 (1)
OFFER PRICE (QTY) 1659.80 (13)
VOLUME 25523
TODAY'S LOW / HIGH( ) 1650.10 1675.30
52 WK LOW / HIGH ( )900.05 1725
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984
Management Info
Sudhir Vaid - Chairman Sudhir Vaid - Managing Director
Registered Office

Address 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone 079-68138700

Email complianceofficer@concordbiotech.com

Website www.concordbiotech.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
15Apr Reply To Clarification Sought On Volu
We hereby submit that the company has disclosed all the material informa..
06Mar Concord Biotech informs about updates
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclo..
23Feb Concord Biotech gets GMP for unit II o
Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has com..
23Feb Concord Biotech gains on getting GMP f
Concord Biotech is currently trading at Rs. 1463.65, up by 23.40 points..
09Feb Concord Biotech informs about investor
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obliga..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL
Net Profit745.54
Gross Profit 1000.85
Operating Profit 1141.17
Net Sales
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8650.00 (3.92%)
M.Cap (Rs. in Cr)19893.85
Abbott India (BSE)
 26637.05 (0.84%)
M.Cap (Rs. in Cr)56697.60
NGL Fine-Chem (BSE)
 2653.95 (4.17%)
M.Cap (Rs. in Cr)1646.84
Dr. Reddy's Lab (BSE)
 6275.00 (1.13%)
M.Cap (Rs. in Cr)104511.64
Pfizer (BSE)
 4308.75 (1.30%)
M.Cap (Rs. in Cr)19690.28
MORE
Shareholding Pattern
PROMOTERS 44.08%
NON-INSTITUTION 41.03%
MUTUAL FUNDS/UTI 5.15%
FI/BANKS/INSURANCE 2.88%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.